The Pransky interview: Aldo Zini, President and CEO of Aethon, Inc.

Purpose – The following paper is a “Q & A interview” conducted by Joanne Pransky of Industrial Robot Journal as a method to impart the combined technological, business and personal experience of a prominent, robotic industry engineer-turned successful business leader, regarding the commercialization and challenges of bringing technological inventions to market while overseeing a company. This paper aims to discuss these issues. Design/methodology/approach – The interviewee is Aldo Zini, President and CEO of Aethon, Inc., a robotics and software company that has developed an innovative automated platform to improve internal supply logistics. In this interview, Zini shares some of the technical and business details that have led up to the latest version of Aethon’s core product, the TUG, a mobile autonomous robot with more than 450 installs worldwide. Findings – Zini received a BS in Industrial Engineering from the University of Pittsburgh and a master’s in Public Management (Health Systems IT) from Carnegie Mellon University. While obtaining his BS degree, Zini did an internship in hospital consulting and became immediately interested in healthcare automation as a way to solve hospital inefficiencies. Zini went on to become the Vice President of Sales and Marketing for Automated Healthcare, which developed the first robotic medication dispensing system for hospitals (ROBOT-Rx) and was acquired by McKesson for $67 million. Before joining and investing in Aethon, Zini was Senior Vice President of sales and marketing for TechRx, one of the largest providers of software solutions to the pharmacy industry, which was sold to NDC Corporation for over $200 million. Originality/value – Zini has been leading the technology revolution in hospital automation for more than 25 years. His contributions to technology-driven companies have led to acquisitions worth more than a quarter of a billion dollars. Zini owns several patents in medication-dispensing technology, and is credited with the development of key methodologies in quantifying the value proposition for several technology platforms deployed in hundreds of hospitals across the country.